Manulife (Manufacturers Life Insurance)’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.8K | Sell |
24,351
-15,159
| -38% | -$65.7K | ﹤0.01% | 2678 |
|
|
2025
Q4 | $141K | Sell |
39,510
-2,216
| -5% | -$13.6K | ﹤0.01% | 2637 |
|
|
2025
Q3 | $371K | Buy |
41,726
+11,377
| +37% | +$115K | ﹤0.01% | 2315 |
|
|
2025
Q2 | $280K | Buy |
30,349
+3,274
| +12% | +$27.9K | ﹤0.01% | 2414 |
|
|
2025
Q1 | $232K | Sell |
27,075
-667
| -2% | -$6.3K | ﹤0.01% | 2429 |
|
|
2024
Q4 | $298K | Sell |
27,742
-1,992
| -7% | -$15.3K | ﹤0.01% | 2452 |
|
|
2024
Q3 | $169K | Sell |
29,734
-776
| -3% | -$4.48K | ﹤0.01% | 2725 |
|
|
2024
Q2 | $129K | Buy |
30,510
+2,401
| +9% | +$9.71K | ﹤0.01% | 2754 |
|
|
2024
Q1 | $143K | Buy |
28,109
+969
| +4% | +$5.45K | ﹤0.01% | 2695 |
|
|
2023
Q4 | $253K | Hold |
27,140
| – | – | ﹤0.01% | 2499 |
|
|
2023
Q3 | $178K | Buy |
27,140
+92
| +0.3% | +$732 | ﹤0.01% | 2647 |
|
|
2023
Q2 | $220K | Buy |
27,048
+1,503
| +6% | +$12.9K | ﹤0.01% | 2555 |
|
|
2023
Q1 | $219K | Hold |
25,545
| – | – | ﹤0.01% | 2497 |
|
|
2022
Q4 | $237K | Sell |
25,545
-67
| -0.3% | -$716 | ﹤0.01% | 2454 |
|
|
2022
Q3 | $264K | Sell |
25,612
-606
| -2% | -$6.39K | ﹤0.01% | 2384 |
|
|
2022
Q2 | $262K | Buy |
26,218
+595
| +2% | +$5.64K | ﹤0.01% | 2478 |
|
|
2022
Q1 | $315K | Buy |
+25,623
| New | +$315K | ﹤0.01% | 2481 |
|
|
2021
Q4 | – | Sell |
-31,809
| Closed | -$571K | – | 3116 |
|
|
2021
Q3 | $571K | Sell |
31,809
-2,307
| -7% | -$45.9K | ﹤0.01% | 2187 |
|
|
2021
Q2 | $780K | Buy |
34,116
+1,963
| +6% | +$29.1K | ﹤0.01% | 2135 |
|
|
2021
Q1 | $481K | Sell |
32,153
-839
| -3% | -$9.16K | ﹤0.01% | 2304 |
|
|
2020
Q4 | $178K | Buy |
32,992
+1,764
| +6% | +$9.3K | ﹤0.01% | 2815 |
|
|
2020
Q3 | $142K | Hold |
31,228
| – | – | ﹤0.01% | 2694 |
|
|
2020
Q2 | $158K | Buy |
31,228
+575
| +2% | +$2.17K | ﹤0.01% | 2599 |
|
|
2020
Q1 | $97K | Buy |
30,653
+2,754
| +10% | +$9.6K | ﹤0.01% | 2587 |
|
|
2019
Q4 | $72K | Sell |
27,899
-1,765
| -6% | -$4.63K | ﹤0.01% | 2837 |
|
|
2019
Q3 | $99K | Hold |
29,664
| – | – | ﹤0.01% | 2821 |
|
|
2019
Q2 | $100K | Buy |
+29,664
| New | +$92.1K | ﹤0.01% | 2885 |
|
|
2018
Q1 | – | Sell |
-6,327
| Closed | -$20K | – | 4322 |
|
|
2017
Q4 | $20K | Sell |
6,327
-12,862
| -67% | -$50.6K | ﹤0.01% | 3794 |
|
|
2017
Q3 | $79K | Sell |
19,189
-12,687
| -40% | -$56.4K | ﹤0.01% | 3388 |
|
|
2017
Q2 | $169K | Buy |
31,876
+8,728
| +38% | +$50.5K | ﹤0.01% | 3145 |
|
|
2017
Q1 | $133K | Hold |
23,148
| – | – | ﹤0.01% | 3057 |
|
|
2016
Q4 | $91K | Buy |
23,148
+16,307
| +238% | +$58.1K | ﹤0.01% | 3266 |
|
|
2016
Q3 | $25K | Sell |
6,841
-16,429
| -71% | -$69.2K | ﹤0.01% | 3529 |
|
|
2016
Q2 | $142K | Buy |
+23,270
| New | +$112K | ﹤0.01% | 2990 |
|
Other funds holding AVXL
VCM
SF
VPM
Manulife (Manufacturers Life Insurance)'s AVXL Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Anavex Life Sciences (AVXL) stake by 38% in Q1 2026, selling an estimated $65.7K and leaving 24,351 shares worth $74.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.
Manulife (Manufacturers Life Insurance) first reported a position in AVXL in Q2 2016 and has held it in 34 quarters since. The position peaked at $780K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 24,351 shares of Anavex Life Sciences worth $74.8K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 15,159 Anavex Life Sciences shares in Q1 2026, an estimated $65.7K.
- Anavex Life Sciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2678 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 34 quarters since.
- Manulife (Manufacturers Life Insurance)'s Anavex Life Sciences position peaked at $780K in Q2 2021.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.